Arcturus Therapeutics Holdings Inc (ARCT) — Cash Flow Reinvestment Rate

Latest as of June 2023: 0.01x

Arcturus Therapeutics Holdings Inc (ARCT) has a Cash Flow Reinvestment Rate of 0.01x as of June 2023, reinvesting $708.00K (capex $354.00K plus investments $-354.00K) from operating cash flow of $50.81 Million. Explore capital reinvestment ratio of Arcturus Therapeutics Holdings Inc to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.01x

(Capex + Investments) / Operating CF

Total Reinvested

$708.00K

Capex + Investments

Operating Cash Flow

$50.81 Million

USD

Capital Expenditures

$354.00K

USD

Arcturus Therapeutics Holdings Inc Cash Flow Reinvestment Rate (2022–2022)

Historical reinvestment intensity for Arcturus Therapeutics Holdings Inc across 1 annual periods. Also explore ARCT total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Arcturus Therapeutics Holdings Inc (2022–2022)

Year-by-year capital reinvestment analysis for Arcturus Therapeutics Holdings Inc. For live market cap and broader valuation context, see Arcturus Therapeutics Holdings Inc (ARCT) total market value.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2022	0.48x	$15.45 Million	$31.99 Million	$7.73 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow